Jellagen launches jellyfish collagen manufacturing facility
25 May 2017 | By Niamh Marriott, Junior Editor
A pioneering medical technology firm has launched a unique manufacturing facility to extract collagen from jellyfish.
List view / Grid view
News
Brilique (ticagrelor) new formulation gains European approval
25 May 2017 | By Niamh Marriott, Junior Editor
The European Commission has granted marketing authorisation for AstraZeneca’s Brilique (ticagrelor) orodispersible tablets (ODT) as a new formulation...
Motor neurone disease onset delayed by AI-discovered drug
25 May 2017 | By Niamh Marriott, Junior Editor
The study assessed the efficacy of a drug candidate proposed by BenevolentAI’s artificial Intelligence technology for Motor Neuron Disease (MND)...
Wickham Laboratories announces upcoming webinar on In-Vitro Alternatives
25 May 2017 | By Wickham Laboratories
Join us for a free webinar to discuss the challenges of transitioning from in-vivo to in-vitro methods...
FDA approves first cancer treatment for any solid tumor with a specific biomarker
24 May 2017 | By Niamh Marriott, Junior Editor
The US Food and Drug Administration granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature (biomarker)...
AstraZeneca enters agreement with Recordati for Seloken in Europe
24 May 2017 | By Niamh Marriott, Junior Editor
AstraZeneca has entered into an agreement with Recordati for the commercial rights to Seloken/Seloken ZOK treatments in Europe...
Tablet helps heart failure patients manage drug dosages
24 May 2017 | By Niamh Marriott, Junior Editor
A novel tablet is helping heart failure patients to manage their disease including drug dosages, according to new research...
Better, cheaper healthcare with dry blood samples
24 May 2017 | By Niamh Marriott, Junior Editor
In a new study, Uppsala University researchers have successfully measured 92 different proteins in millimetre-sized circles punched out of dried samples...
FDA approves Merck’s bladder cancer drug
24 May 2017 | By Niamh Marriott, Junior Editor
The FDA has approved two new indications for Merck’s Keytruda (pembrolizumab), the company’s anti-PD-1 therapy, for bladder cancer...
Zika Virus assay for screening blood donations
23 May 2017 | By Niamh Marriott, Junior Editor
Grifols now provides European countries accepting products with the CE marking with a test to detect the presence of the Zika virus in donated blood.
Patent library will be founded in Lithuania
23 May 2017 | By Niamh Marriott, Junior Editor
The State Patent Bureau of the Republic of Lithuania (SPB) and Kaunas University of Technology National Innovation and Entrepreneurship Centre (KTU NIEC) has signed the collaboration agreement, which laid foundation for the new Patent Library – PATLIB Centre. This will be the first time, when a PATLIB Centre is established…
Biosimilar medicines: Dramatic increase in patient access across Europe
23 May 2017 | By Niamh Marriott, Junior Editor
Biosimilar medicines have dramatically increased patient access to biological medicines, according to the recently published QuintilesIMS report...
Antibiotic therapy for nearly 1 in 4 adults with pneumonia does not work
22 May 2017 | By Niamh Marriott, Junior Editor
Approximately one in four adults prescribed an antibiotic in an outpatient setting for community-acquired pneumonia does not respond to treatment...
Pfizer collaboration to reduce injectable contraceptive price
22 May 2017 | By Niamh Marriott, Junior Editor
Pfizer have announced an extension of their collaboration to further broaden access to Pfizer’s all-in-one injectable contraceptive...
Bonesupport enrols first patient in injectable bone graft substitute trial
22 May 2017 | By Niamh Marriott, Junior Editor
Bonesupport, the Scandinavian medical technology company, has enrolled their first patient at the University of Texas Health Science Center at San Antonio into the company’s pivotal Investigational Device Exemption (IDE) trial. Cerament G is an injectable antibiotic-eluting bone graft substitute that has proven remodelling capabilities and provides local sustained delivery…
